Prescription Pricing for the People Act of 2023
- Introduced Jan 26
- Committee Jan 26
- Passed Senate Next
- Passed House Not yet
- To President Not yet
- Law Not yet
Where it stands
In committee, Jan 26, 2023Next: Senate vote
1337d ago Mar 1, 2023: Placed on Senate Legislative Calendar under General Orders. Calendar No. 19.
Final votes
No roll callsNo recorded vote on this bill yet
Who backs the bill and who pushes back Subscribe
Companies lobbying on this bill
6 companiesCompanies by sector
Biotech & Pharma 4Financials 2
Search all 6 companies, their asks and price moves Subscribe
Votes
No recorded roll-call vote on this bill yet
Member trades
Member trades around the votes Subscribe
Summary
Prescription Pricing for the People Act of 2023
Full summary1 paragraphs
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Library of Congress summary, Mar 1, 2023
Summary versions
- Reported to SenateMar 1, 2023
- Introduced in SenateJan 26, 2023
Actions
- SenateCommittee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.Mar 1, 2023
- SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 19.Mar 1, 2023
- SenateCommittee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.Feb 9, 2023
- SenateIntroduced in SenateJan 26, 2023
- SenateRead twice and referred to the Committee on the Judiciary.Jan 26, 2023
Bill record
Text versions2
- Reported to SenateMar 1, 2023PDF: Reported to Senate
- Introduced in SenateJan 26, 2023PDF: Introduced in Senate
Committees1
- Senate Judiciary CommitteeReported By Mar 1, 2023Markup By, Feb 9, 2023Referred To, Jan 26, 2023
Sponsor and cosponsors21 cosponsors
- Sen. Chuck Grassley (R-IA)Sponsor, Jan 26, 2023
- James Lankford (R-OK)OriginalJoined Jan 26, 2023
- Maria Cantwell (D-WA)OriginalJoined Jan 26, 2023
- Marsha Blackburn (R-TN)OriginalJoined Jan 26, 2023
- Mike Braun (R-IN)OriginalJoined Jan 26, 2023
- Richard Blumenthal (D-CT)OriginalJoined Jan 26, 2023
- Shelley Capito (R-WV)OriginalJoined Jan 26, 2023
- Thomas Tillis (R-NC)OriginalJoined Jan 26, 2023
- Tommy Tuberville (R-AL)OriginalJoined Jan 26, 2023
- John Boozman (R-AR)Joined Jan 30, 2023
- Christopher Coons (D-DE)Joined Feb 7, 2023
- Peter Welch (D-VT)Joined Feb 7, 2023
- Dianne Feinstein (D-CA)Joined Feb 9, 2023
- Mazie Hirono (D-HI)Joined Feb 9, 2023
- Bob Casey (D-PA)Joined Mar 16, 2023
- Kyrsten Sinema (I-AZ)Joined Mar 21, 2023
- Roger Marshall (R-KS)Joined Mar 29, 2023
- Ted Budd (R-NC)Joined Apr 19, 2023
- Jacklyn Rosen (D-NV)Joined Sep 27, 2023
- Jeanne Shaheen (D-NH)Joined Nov 9, 2023
- Susan Collins (R-ME)Joined Nov 9, 2023
- Raphael Warnock (D-GA)Joined Jul 10, 2024
Amendments0
No amendments offered
Cost estimates and reports1
- CBO: S. 113, Prescription Pricing for the People Act of 2023Mar 31, 2023As ordered reported by the Senate Committee on the Judiciary on February 9, 2023
Titles2
Short titles
- Prescription Pricing for the People Act of 2023Short Title(s) as Introduced
Official titles
- A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.Official Title as Introduced
Subjects11
Policy area
Legislative subjects
Business ethicsBusiness recordsCompetition and antitrustCongressional oversightConsumer affairsHealth care costs and insuranceHealth information and medical recordsInflation and pricesPrescription drugsRetail and wholesale trades
Related bills1
- S. 1388 117th, Reintroduction of Prescription Pricing for the People Act of 2021
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.